Skip to main content

Table 7 Cox proportional-hazards regression: univariate and multivariate analyses according to normal weight (18.5-25), overweight (25-30) and obese (≥ 30) BMI levels

From: A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

  Univariate Analysis Multivariate Analysis
VARIABLE
(Comparator)
HR (95% CI); p - value HR (95% CI); p - value
BMI
(18.5–25)
Time to Treatment Failure
25–30
≥ 30
0.51 (0.43–0.61); p < 0.0001
0.63 (0.49–0.81); p = 0.0003
0.65 (0.51–0.82); p = 0.0004
0.79 (0.55–1.15); p = 0.2300
BMI
(18.5–25)
Progression Free Survival
25–30
≥ 30
0.49 (0.41–0.58); p < 0.0001
0.48 (0.37–0.64); p < 0.0001
0.68 (0.53–0.87); p = 0.0016
0.72 (0.49–1.06); p = 0.0991
BMI
(18.5–25)
Overall Survival
25–30
≥ 30
0.35 (0.29–0.43); p < 0.0001
0.37 (0.27–0.51); p < 0.0001
0.46 (0.35–0.61); p < 0.0001
0.50 (0.32–0.79); p = 0.0029
  1. The used covariates (not shown) were: weight (continuous), irAEs of any grade, primary tumors, sex, line of treatment, ECOG-PS, number of metastatic sites